Status:
COMPLETED
Perioperative Respiratory Adverse events_sugammadex
Lead Sponsor:
Seoul National University Hospital
Conditions:
Respiratory Complication
Eligibility:
All Genders
2-6 years
Phase:
PHASE4
Brief Summary
Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of sugammadex on the incidence of perioperative respiratory adverse events in pediatric patients receiv...
Eligibility Criteria
Inclusion
- Pediatric patients aged 2-6 years who were scheduled for tonsillectomy under general anesthesia were enrolled
Exclusion
- a recent history of upper respiratory tract infection within 2 weeks of surgery
- allergic reaction to sugammadex
- renal failure
- liver failure
- arrhythmia
Key Trial Info
Start Date :
June 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 4 2024
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT05354466
Start Date
June 27 2022
End Date
September 4 2024
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul national university hospital
Seoul, South Korea